Rare diseases
Investigational molecules
Locations
Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer
SpainStudy on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement
FranceStudy on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel
PolandStudy of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
BelgiumStudy Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer
FranceStudy on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer
FranceStudy on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer
FranceStudy on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
AustriaStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
BelgiumStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceDurvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
